| Issuer | % of Class | Filed |
|---|---|---|
|
Neumora Therapeutics, Inc.
13G/A
Amendment 2
NMRA · 640979100
|
5.4% |
11/16/2026
Event 9/30/2026
|
|
Neumora Therapeutics, Inc.
13G/A
Amendment 1
NMRA · 640979100
|
5.1% |
2/13/2025
Event 12/31/2024
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.